IAIM
TSHA icon

International Assets Investment Management’s Taysha Gene Therapies TSHA Stock Holding History

International Assets Investment Management’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Hold
2,000
– – ﹤0.01% 1733
2026
Q1 		$8.62K Hold
2,000
– – ﹤0.01% 1717
2025
Q4 		$11K Buy
+2,000
New +$9.71K ﹤0.01% 1633
2024
Q4 		– Sell
-4,020
Closed -$2K – 1857
2024
Q3 		$2K Buy
4,020
+2,020
+101% +$4.43K 0.01% 901
2024
Q2 		$4.48K Buy
+2,000
New +$5.82K ﹤0.01% 1871

Other funds holding TSHA

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
AWM
Affinity Wealth Management Wilmington, Delaware $776M AUM 43.59% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
RRA
Red Reef Advisors Boca Raton, Florida $108M AUM
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

International Assets Investment Management's TSHA Position: Q2 2026 in Review

International Assets Investment Management held its Taysha Gene Therapies (TSHA) position steady in Q2 2026 at 2,000 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1733.

International Assets Investment Management first reported a position in TSHA in Q2 2024 and has held it in 5 quarters since. 30 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • International Assets Investment Management held 2,000 shares of Taysha Gene Therapies worth $13.3K as of Q2 2026.
  • International Assets Investment Management left its Taysha Gene Therapies share count unchanged in Q2 2026.
  • Taysha Gene Therapies made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1733 holding.
  • International Assets Investment Management first reported a position in Taysha Gene Therapies in Q2 2024 and has held it in 5 quarters since.
  • 30 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.